iANTHUS CAPITAL HOLDINGS (ITHUF) Other Non-Current Liabilities (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Other Non-Current Liabilities came in at $2.6 million in Q1 2026, up 1418.39% year-on-year from $174000.0 in Q1 2025, and up 13.93% quarter-over-quarter from $2.3 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $2.6 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $2.6 million, up 1418.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 1418.39% YoY), and the FY2025 annual result was $2.3 million, down 25.84% from the prior year.
- Other Non-Current Liabilities came in at $2.6 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $2.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $3.7 million in Q2 2025 to a low of $4.0 in Q1 2022.
- The 4-year median for Other Non-Current Liabilities is $2.6 million (2026), against an average of $2.1 million.
- Across the five-year window, Other Non-Current Liabilities plunged 98.58% in 2022 and surged 1418.39% in 2026, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Other Non-Current Liabilities stood at $4.0 in 2022, then jumped by 78174900.0% to $3.1 million in 2024, then decreased by 25.84% to $2.3 million in 2025, then rose by 13.93% to $2.6 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $2.6 million (Q1 2026), $2.3 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 3.68 Mn |
| Mar 31, 2025 | 174,000.00 |
| Dec 31, 2024 | 3.13 Mn |
| Mar 31, 2022 | 4.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 315.00 |
| Jun 30, 2021 | 136.00 |
| Mar 31, 2021 | 282.00 |
| Dec 31, 2020 | 245,000.00 |